House Ways and Means Committee leaders today released a white paper summarizing stakeholder recommendations for Medicare-related legislation to address the opioid crisis, which the committee plans to use to develop and advance bipartisan policies. The committee in February requested feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. “We are hopeful this legislation will touch on many of the stakeholder recommendations, including but not limited to those related to Medicare treatment options/coverage, improving data tracking/prescribing practices, and educating providers and beneficiaries about the risks of long-term opioid use,” the white paper states. AHA submitted its policy recommendations to the committee last month.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services yesterday released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s…
Headline
Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs…
Headline
The Government Accountability Office today named three new members to the Medicare Payment Advisory Commission through April 2023. They are: Wayne…
Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM)…
Headline
More than half of U.S. adults aged 70 and older have experienced a disruption in their medical care during the first month of social distancing for COVID-19,…